Sign In   |   Register

EAS 2019 Congress Maastricht, The Netherlands, May 26-29

The European Atherosclerosis Society (EAS) and the Dutch Atherosclerosis Society welcome you to the Netherlands, to the charming and historic city of Maastricht and the 87th EAS Congress.

During the meeting we will explore the latest developments in research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment. Clinicians and basic researchers studying atherosclerosis and related vascular disease are welcome to submit an abstract, to present their findings to the international scientific community at EAS 2019.

Please check the Congress website and download the Congress App for the scientific programme details and practical information to help you get the most out of your visit to Maastricht.

To EAS 2019 and the full programme >>

Travelling to Maastricht >>

The Congress App >>

The European Atherosclerosis Society FH Studies Collaboration and FH Europe announce partnership

One voice in Europe on FH

We are excited to announce a new collaboration between Familial Hypercholesterolaemia (FH) patient representative network, FH Europe, and the FH investigators from all over the world who work together as part of the EAS FH Studies Collaboration (FHSC).

FH continues to be a major global health problem, very common — worldwide, one in every 200‑500 people has FH — yet widely underdiagnosed and undertreated. Most people who have FH do not know they have it. These people have inherited high cholesterol, and are at risk for premature atherosclerosis and early cardiovascular events that are often fatal. But if FH is identified early, and effective treatment begun, individuals with FH can live long and healthy lives.

Through this collaboration FH Europe and the FHSC will speak withone voice on FH, and by linking FH patient groups with expert clinicians from all over the world, we will share globally established best practices that will mean more persons with FH are identified early and, once they are identified, a smoother pathway for the patient to referral and potentially life-saving treatment in the clinic.

We will work together on our common goals towards improving care for FH patients: working within the FH community with initiatives reducing gaps in knowledge, informing best practice, assisting in clinical trials design, and supporting clinical guidelines and development of policies; reaching outside the FH community by raising awareness of the burden of FH among healthcare professionals and policy-makers, and advancing global public policy on FH.

Lale Tokgozoglu
President, EAS

Kausik Ray
Alberico L. Catapano
FHSC Co-lead
Jules Payne
Chair, FH Europe

Read the full press release >>

Read more about EAS FH Studies Collaboration >>

Read more about FH Europe >>

From the EAS President:

Want to know more about our Society and current activities? Read the review and reflection on the progress we have made in the Society’s activities during 2018 and our plans for 2019 here.

Lale Tokgozoglu MD FACC FESC
President, European Atherosclerosis Society
Professor of Cardiology
Hacettepe University

Member sign in

Access the Society journals

Log in to access Atherosclerosis >>

Calendar more

26/05/2019 » 29/05/2019
87th EAS Congress - Maastricht

02/07/2019 » 04/07/2019
EAS Advanced Course in Cardiometabolic Phenotyping in animal models in Cambridge, United Kingdom

EAS Academy
EAS Journal
Become an EAS Member
Membership Software Powered by YourMembership  ::  Legal